Literature DB >> 28188825

Antibiotics, gut microbiota, environment in early life and type 1 diabetes.

Youjia Hu1, F Susan Wong2, Li Wen3.   

Abstract

The gut microbiota interact with innate immune cells and play an important role in shaping the immune system. Many factors may influence the composition of the microbiota such as mode of birth, diet, infections and medication including antibiotics. In diseases with a multifactorial etiology, like type 1 diabetes, manipulation and alterations of the microbiota in animal models have been shown to influence the incidence and onset of disease. The microbiota are an important part of the internal environment and understanding how these bacteria interact with the innate immune cells to generate immune tolerance may open up opportunities for development of new therapeutic strategies. In this review, we discuss recent findings in relation to the microbiota, particularly in the context of type 1 diabetes.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Gut microbiota; Immune regulation; Neonatal immune response; Type 1 diabetes

Mesh:

Substances:

Year:  2017        PMID: 28188825      PMCID: PMC5392439          DOI: 10.1016/j.phrs.2017.01.034

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  123 in total

Review 1.  The role of the intestinal microbiota in type 1 diabetes mellitus.

Authors:  Mikael Knip; Heli Siljander
Journal:  Nat Rev Endocrinol       Date:  2016-01-04       Impact factor: 43.330

2.  Gram-positive and gram-negative bacteria induce different patterns of cytokine production in human mononuclear cells irrespective of taxonomic relatedness.

Authors:  Susann Skovbjerg; Anna Martner; Lars Hynsjö; Christina Hessle; Ingar Olsen; Floyd E Dewhirst; Wilhelm Tham; Agnes E Wold
Journal:  J Interferon Cytokine Res       Date:  2010-01       Impact factor: 2.607

3.  Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns.

Authors:  Maria G Dominguez-Bello; Elizabeth K Costello; Monica Contreras; Magda Magris; Glida Hidalgo; Noah Fierer; Rob Knight
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

4.  Impact of Ciprofloxacin and Clindamycin Administration on Gram-Negative Bacteria Isolated from Healthy Volunteers and Characterization of the Resistance Genes They Harbor.

Authors:  Roderick M Card; Muriel Mafura; Theresa Hunt; Miranda Kirchner; Jan Weile; Mamun-Ur Rashid; Andrej Weintraub; Carl Erik Nord; Muna F Anjum
Journal:  Antimicrob Agents Chemother       Date:  2015-05-18       Impact factor: 5.191

Review 5.  The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity.

Authors:  Ningwen Tai; F Susan Wong; Li Wen
Journal:  Rev Endocr Metab Disord       Date:  2015-03       Impact factor: 6.514

6.  Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity.

Authors:  Janet G M Markle; Daniel N Frank; Steven Mortin-Toth; Charles E Robertson; Leah M Feazel; Ulrike Rolle-Kampczyk; Martin von Bergen; Kathy D McCoy; Andrew J Macpherson; Jayne S Danska
Journal:  Science       Date:  2013-01-17       Impact factor: 47.728

7.  Innate immunity and intestinal microbiota in the development of Type 1 diabetes.

Authors:  Li Wen; Ruth E Ley; Pavel Yu Volchkov; Peter B Stranges; Lia Avanesyan; Austin C Stonebraker; Changyun Hu; F Susan Wong; Gregory L Szot; Jeffrey A Bluestone; Jeffrey I Gordon; Alexander V Chervonsky
Journal:  Nature       Date:  2008-09-21       Impact factor: 49.962

8.  Diversity and composition of the adult fecal microbiome associated with history of cesarean birth or appendectomy: Analysis of the American Gut Project.

Authors:  James J Goedert; Xing Hua; Guoqin Yu; Jianxin Shi
Journal:  EBioMedicine       Date:  2014-12-01       Impact factor: 8.143

9.  Prolonged transfer of feces from the lean mice modulates gut microbiota in obese mice.

Authors:  Maria Kulecka; Agnieszka Paziewska; Natalia Zeber-Lubecka; Filip Ambrozkiewicz; Michal Kopczynski; Urszula Kuklinska; Kazimiera Pysniak; Marta Gajewska; Michal Mikula; Jerzy Ostrowski
Journal:  Nutr Metab (Lond)       Date:  2016-08-23       Impact factor: 4.169

10.  Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose Metabolism.

Authors:  Kristian H Mikkelsen; Morten Frost; Martin I Bahl; Tine R Licht; Ulrich S Jensen; Jacob Rosenberg; Oluf Pedersen; Torben Hansen; Jens F Rehfeld; Jens J Holst; Tina Vilsbøll; Filip K Knop
Journal:  PLoS One       Date:  2015-11-12       Impact factor: 3.240

View more
  19 in total

Review 1.  The crucial role of early-life gut microbiota in the development of type 1 diabetes.

Authors:  He Zhou; Lin Sun; Siwen Zhang; Xue Zhao; Xiaokun Gang; Guixia Wang
Journal:  Acta Diabetol       Date:  2020-07-25       Impact factor: 4.280

2.  Thiazolides promote G1 cell cycle arrest in colorectal cancer cells by targeting the mitochondrial respiratory chain.

Authors:  P Ripani; J Delp; K Bode; M E Delgado; L Dietrich; V M Betzler; N Yan; G von Scheven; T U Mayer; M Leist; T Brunner
Journal:  Oncogene       Date:  2019-12-16       Impact factor: 9.867

3.  Maternal antibiotics disrupt microbiome, behavior, and temperature regulation in unexposed infant mice.

Authors:  Christopher Harshaw; Sayuri Kojima; Cara L Wellman; Gregory E Demas; Ardythe L Morrow; Diana Hazard Taft; William M Kenkel; Joseph K Leffel; Jeffrey R Alberts
Journal:  Dev Psychobiol       Date:  2022-09       Impact factor: 2.531

Review 4.  Visceral Adipose Tissue: A New Target Organ in Virus-Induced Type 1 Diabetes.

Authors:  Danny Zipris
Journal:  Front Immunol       Date:  2021-08-04       Impact factor: 7.561

Review 5.  Old Fashioned vs. Ultra-Processed-Based Current Diets: Possible Implication in the Increased Susceptibility to Type 1 Diabetes and Celiac Disease in Childhood.

Authors:  Sandra V Aguayo-Patrón; Ana M Calderón de la Barca
Journal:  Foods       Date:  2017-11-15

Review 6.  Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetes.

Authors:  Arata Itoh; William M Ridgway
Journal:  Immunotargets Ther       Date:  2017-05-19

7.  Sex dependent effects of post-natal penicillin on brain, behavior and immune regulation are prevented by concurrent probiotic treatment.

Authors:  Marya Kayyal; Tanvi Javkar; M Firoz Mian; Dana Binyamin; Omry Koren; Karen-Anne McVey Neufeld; Paul Forsythe
Journal:  Sci Rep       Date:  2020-06-25       Impact factor: 4.379

8.  Maternal cecal microbiota transfer rescues early-life antibiotic-induced enhancement of type 1 diabetes in mice.

Authors:  Xue-Song Zhang; Yue Sandra Yin; Jincheng Wang; Thomas Battaglia; Kimberly Krautkramer; Wei Vivian Li; Jackie Li; Mark Brown; Meifan Zhang; Michelle H Badri; Abigail J S Armstrong; Christopher M Strauch; Zeneng Wang; Ina Nemet; Nicole Altomare; Joseph C Devlin; Linchen He; Jamie T Morton; John Alex Chalk; Kelly Needles; Viviane Liao; Julia Mount; Huilin Li; Kelly V Ruggles; Richard A Bonneau; Maria Gloria Dominguez-Bello; Fredrik Bäckhed; Stanley L Hazen; Martin J Blaser
Journal:  Cell Host Microbe       Date:  2021-07-21       Impact factor: 31.316

9.  Managing antibiotics wisely: a quality improvement programme in a tertiary neonatal unit in the UK.

Authors:  Vasiliki Makri; Gemma Davies; Stephanie Cannell; Katherine Willson; Lucy Winterson; Joanna Webb; Amit Kandhari; Maha Mansour; Joanne Thomas; Geraint Morris; Jean Matthes; Sujoy Banerjee
Journal:  BMJ Open Qual       Date:  2018-05-07

10.  The DNA Sensor AIM2 Protects against Streptozotocin-Induced Type 1 Diabetes by Regulating Intestinal Homeostasis via the IL-18 Pathway.

Authors:  Jefferson Antônio Leite; Gabriela Pessenda; Isabel C Guerra-Gomes; Alynne Karen Mendonça de Santana; Camila André Pereira; Frederico Ribeiro Campos Costa; Simone G Ramos; Dario Simões Zamboni; Ana Maria Caetano Faria; Danilo Candido de Almeida; Niels Olsen Saraiva Câmara; Rita C Tostes; João Santana Silva; Daniela Carlos
Journal:  Cells       Date:  2020-04-14       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.